Literature DB >> 11109650

[Mucinous adenocarcinoma of the appendix associated with ovarian tumors and pseudomyxoma peritonei. The difficulty in differential diagnosis].

C Ciriza1, S Valerdiz, C Toribio, S Dajil, M J Romero, O Urquiza, G Karpman.   

Abstract

Mucinous adenocarcinoma of the appendix is rare. If there is a concomitant ovarian tumor to determine the primary might be difficult. Histological features are not always determinant, but there are some macroscopic findings that may suggest an origin in the appendix. We report a case of synchronous tumors in appendix and ovaries with pseudomyxoma peritonei. The patient presented with mass sensation in the right lower quadrant, asthenia, anorexia and weight loss. Abdominal ultrasound and CT scan showed a tumor involving cecum, appendix, terminal ileum and pelvis. Findings on colonoscopy and biopsies were inconclusive. At laparotomy, the tumor compressed appendix, cecum and ascendant colon, terminal ileum, ovaries and peritoneum. Histopathological analysis demonstrated a well-differentiated mucinous adenocarcinoma of appendiceal origin with metastasis in ovaries and peritoneum (pseudomyxoma peritonei).

Entities:  

Mesh:

Year:  2000        PMID: 11109650

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  3 in total

Review 1.  Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines.

Authors:  Sandra Pinzón Martín; Peter H Seeberger; Daniel Varón Silva
Journal:  Front Chem       Date:  2019-10-22       Impact factor: 5.221

2.  Endometrial adenocarcinoma and mucocele of the appendix: an unusual coexistence.

Authors:  Ioannis Kalogiannidis; Amalia Mavrona; Sophia Grammenou; Georgios Zacharioudakis; Stamatia Aggelidou; David Rousso
Journal:  Case Rep Obstet Gynecol       Date:  2013-05-16

Review 3.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.